Specifications Manual for Joint Commission National Quality Measures (v2025A)
Posted: 09/13/2024

Release Notes:
IntroductionTJC
Version 2025A

Introduction and Background

The Joint Commission Quality Initiative

In 1987, The Joint Commission announced its Agenda for Change, which outlined a series of major steps designed to modernize the accreditation process. A key component of the Agenda for Change was the eventual introduction of standardized core performance measures into the accreditation process. As the vision to integrate performance measurement into accreditation became more focused, the name ORYX® was chosen for the entire initiative. ORYX® is The Joint Commission's performance measurement and improvement initiative, which integrates outcomes and other performance measure data into the accreditation process.

The ORYX® initiative became operational in March of 1999, when performance measurement systems began transmitting data to The Joint Commission on behalf of accredited hospitals. ORYX® measurement requirements are intended to support Joint Commission accredited organizations in their quality improvement efforts.

The initial phase of the ORYX® initiative provided healthcare organizations a great degree of flexibility in terms of the measures that could be reported. Over time, the ORYX® measures have evolved into standardized valid, reliable, and evidence-based quality measures

The initial CMS/Joint Commission alignment efforts addressed chart-abstracted measures and subsequently both organizations have worked on aligning as closely as possible the electronic clinical quality measures (eCQMs).

Accreditation Process

In January 2000, Joint Commission surveyors began using organization-specific ORYX® Pre-Survey Reports, effectively commencing the use of performance measure data in the survey process.

In 2004, the survey process was substantially modified to be more data-driven and patient-centered thus enhancing its value, relevance, and credibility. Many of the key components of the survey process utilize data derived from the national hospital inpatient quality measures. The survey process now has a greater focus on evaluating actual care processes because patients are traced through the care, treatment and/or services they receive. In addition, surveyors conduct “systems tracers” to analyze key operational systems that directly impact the quality and safety of patient care.

In June 2010 The Joint Commission categorized its process core performance measures into accountability and non-accountability measures.  This approach placed more emphasis on an organization's performance on accountability measures — quality measures that meet four criteria designed to identify measures that produce the greatest positive impact on patient outcomes when hospitals demonstrate improvement:

  • Research:  Strong scientific evidence demonstrates that performing the evidence-based care process improves health outcomes (either directly or by reducing risk of adverse outcomes).
  • Proximity:  Performing the care process is closely connected to the patient outcome; there are relatively few clinical processes that occur after the one that is measured and before the improved outcome occurs.
  • Accuracy: The measure accurately assesses whether or not the care process has actually been provided.  That is, the measure should be capable of indicating whether the process has been delivered with sufficient effectiveness to make improved outcomes likely.
  • Adverse Effects:  Implementing the measure has little or no chance of inducing unintended adverse consequences.

Data Analysis

The Joint Commission has developed a target measure range approach (target analysis) as a basis to evaluate Joint Commission accredited organizations' rating for the performance measures.

The use of target analysis in addition to a control chart is a key feature of the Joint Commission's analytic methods in the ORYX® initiative. The two analyses are alike in that an organization's actual (or observed) performance level is evaluated against a comparative norm, but are fundamentally different as to how such a norm is established. In control chart analysis, the norm is determined from an organization's own historic data so that one may assess the organization's internal process stability. In target analysis, the norm is obtained based on multiple organizations' performance data to evaluate an organization's relative performance level. Therefore, the two analyses evaluate an organization's performance in two distinct perspectives and, as a result, can provide a more comprehensive framework to assess an organization's overall performance level.

Accelerate PI™ Performance Report

The dashboard report displays chart-based and electronic clinical quality measure (eCQM) quality measurement data reported by hospitals to The Joint Commission under the ORYX® program. In addition, the report uses a select subset of the most recent and available external data from the US Centers for Medicare & Medicaid Services (CMS) Compare websites that meet Joint Commission unique criteria for impact and actionability. For each measure, the dashboard shows that organization’s performance compared to national, state, and Joint Commission–accredited organization averages. The dashboard is not a scorable element on survey, but rather, a tool to facilitate discussion about ongoing quality improvement work. The report also includes access to vetted national improvement resources that help organizations explore solutions to challenge areas.

Certification Process

The Joint Commission uses two methodologies for performance measurement for disease-specific care programs. Each certified program collects either standardized or nonstandardized measures, as directed by The Joint Commission. During the certification review the program will demonstrate that it has established a data history that supports quality improvement. Selected standardized measure sets have been incorporated in this specification manual to centralize the measures used for Joint Commission programs into one manual. For more information on the certification process refer to The Joint Commission website and the specific certification program of interest.

Annual Report

Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety was released annually 2008-2017. This comprehensive report summarizes the performance of all Joint Commission-accredited hospitals on ORYX® accountability measures.

Pioneers in Quality

Pioneers in Quality™ is a Joint Commission program started in 2016 to assist hospitals on their journey toward electronic clinical quality measure (eCQM) adoption and reporting. Hospitals collect eCQM information through electronic health records (EHRs) and transmit the data to The Joint Commission (as part of its ORYX® performance measurement requirements) and to the Centers for Medicare & Medicaid Services (CMS). The Pioneers in Quality™ program provides resources to aid hospitals in the transition from chart-abstracted measures to eCQMs. Key components of the Pioneers in Quality™ program include regular educational webinars focused on eCQM adoption, Expert-to-Expert series webinars, a comprehensive eCQM resource portal and recognition for eCQM pioneers in Joint Commission publications.

Direct Data Submission Platform

The Joint Commission began accepting direct data submission of electronic clinical quality measure (eCQM) data from hospitals with the submission of calendar year (CY) 2017 eCQM data. The Direct Data Submission Platform enables an ORYX eCQM process that simplifies operations and reduces the burden for our accredited hospitals while ensuring regulatory compliance and security. Beginning CY 2020 and forward for chart-based measure data, all hospitals will utilize the DDS Platform for submission of data for Accreditation.

CMS Hospital Inpatient Quality Reporting Program

The Hospital Inpatient Quality Reporting Program was originally mandated by Section 501(b) of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003. This section of the MMA authorized CMS to pay hospitals that successfully report designated quality measures a higher annual update to their payment rates. Initially, the MMA provided for a 0.4 percentage point reduction in the annual market basket (the measure of inflation in costs of goods and services used by hospitals in treating Medicare patients) update for hospitals that did not successfully report. The Deficit Reduction Act of 2005 increased that reduction to 2.0 percentage points. This was modified by the American Recovery and Reinvestment Act of 2009 and the Affordable Care Act of 2010, which provided that beginning in fiscal year (FY) 2015, the reduction would be by one-quarter of such applicable annual payment rate update if all Hospital Inpatient Quality Reporting Program requirements are not met.

Under the Hospital Inpatient Quality Reporting Program, CMS collects quality data from hospitals paid under the Inpatient Prospective Payment System, with the goal of driving quality improvement through measurement and transparency by publicly displaying data to help consumers make more informed decisions about their health care. It is also intended to encourage hospitals and clinicians to improve the quality and cost of inpatient care provided to all patients. The data collected through the program are available to consumers and providers on the Hospital Compare website at: https://www.medicare.gov/hospitalcompare/search.html. Data for selected measures are also used for paying a portion of hospitals based on the quality and efficiency of care, including the Hospital Value-Based Purchasing Program, Hospital-Acquired Condition Reduction Program, and Hospital Readmissions Reduction Program.

Hospital Value-Based Purchasing Program

The Hospital VBP Program is part of the CMS’ long-standing effort to link Medicare’s payment system to healthcare quality in the inpatient setting. The program implements value-based purchasing within the payment system that accounts for the largest share of Medicare spending, affecting payment for inpatient stays in approximately 3,000 hospitals across the county. Hospitals are paid for inpatient acute care services based on the quality of care (as evaluated using a select set of quality and cost measures), not just quantity of the services they provide. Section 1886 (o) of the Social Security Act set forth the statutory requirements for the Hospital VBP Program.

The Hospital VBP Program is designed to promote better clinical outcomes for hospital patients, as well as improve their experience of care during hospital stays, while reducing costs to make care affordable. Specifically, the Hospital VBP Program seeks to incentivize hospitals to improve the quality and safety of care that Medicare beneficiaries and all patients receive during acute-care inpatient stays by:
  • Eliminating or reducing the occurrence of adverse events (healthcare errors resulting in patient harm).
  • Adopting evidence-based care standards and protocols that result in the best outcomes for the most patients.
  • Re-engineering hospital processes that improve patients’ experience of care.
  • Increasing the transparency of care for consumers.
  • Recognizing hospitals that are involved in the provision of high-quality care at a lower cost to Medicare.

Electronic Clinical Quality Measures (eCQMs) Overview

Beginning in calendar year (CY) 2013, CMS provided hospitals with the opportunity to voluntarily submit eCQM data. These quality measures were developed specifically to allow an electronic health record (EHR) system certified to the Office of the National Coordinator for Health Information Technology (ONC) standards to capture, export, calculate, and report measure data. Since CY 2016, hospitals have been required to report eCQM data for the Hospital IQR Program and the Medicare Promoting Interoperability Program (previously known as the Medicare EHR Incentive Program). Hospitals that successfully submit eCQM data to meet Hospital IQR Program requirements will also fulfill the Medicare Promoting Interoperability Program requirement for eCQM reporting with one submission.

Refer to the Technical Specifications and Resources for the CMS Quality Reporting Document Architecture (QRDA) Category I Implementation Guide for the applicable reporting period, measure specification information, and program resources to support successful eCQM reporting on the eCQI Resource Center.

Note: Critical access hospitals (CAHs) are required to participate in the Medicare Promoting Interoperability Program and are encouraged but not required to participate in the Hospital IQR Program. Review the Medicare Promoting Interoperability Programs information on the CMS.gov website for more information.

Measures Management System (MMS)

The Measures Management System (MMS) is a standardized system for developing and maintaining the quality measures used in various CMS initiatives and programs. MMS also supports quality-related activities across the agency. Quality measures are tools that help improve the quality of healthcare through an approach that is consistent and accountable.

The primary goals of the MMS are to:
  • Provide support and guidance to measure developers to help them produce high-caliber healthcare quality measures, and
  • Educate and inform stakeholders to promote involvement in and awareness of the Measure Lifecycle.

IntroductionTJC
CPT® only copyright 2024 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2025A)
Discharges 01-01-25 (1Q25) through 06-30-25 (2Q25)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2024 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^